Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: One-year follow-up in five patients

Blood

Volumn 88, Issue 7, 1996, Pages 2801-2806

  Comenzo, Raymond L ^a   Vosburgh, Evan ^b   Simms, Robert W ^b   Bergethon, Peter ^b   Sarnacki, Diane ^b   Finn, Kathleen ^b   Dubrey, Simon ^b   Faller, Douglas V ^b   Wright, Daniel G ^b   Falk, Rodney H ^b   Skinner, Martha ^b  

^a BOSTON MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN; MELPHALAN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AMYLOID NEUROPATHY; AMYLOIDOSIS; ARTICLE; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 10144219963     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2801.bloodjournal8872801     Document Type: Article

References (31)

1. Isobe T, Osserman EF: Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. N Engl J Med 290:473, 1974
2. Glenner GG: Amyloid deposits and amyloidosis: The beta-fibrilloses. N Engl J Med 302:1283, 1980
3. Skinner M, Benson MD, Cohen AS: Amyloid fibril protein related to immunoglobulin light chains. J Immunol 114:1433, 1975
4. Buxbaum J: Mechanisms of disease: Monoclonal immunoglobulin deposition. Hematol Oncol Clin North Am 6:323, 1992
5. Kyle RA, Greipp PR: Amyloidosis (AL): Clinical and laboratory features in 229 cases. Mayo Clin Proc 58:665, 1983
6. Kyle RA, Greipp PR, Garton JP, Gertz MA: Primary systemic amyloidosis: Comparison of melphalan/prednisone versus colchicine. Am J Med 79:708, 1985
7. Kyle RA: "Benign" monoclonal gammopathy - After 20 to 35 years of follow-up. Mayo Clin Proc 63:26, 1993
8. McElwain TJ, Powles RL: High-dose intravenous melphalan for plasma-cell leukemia and myeloma. Lancet 1:822, 1983
9. Barlogie B, Hall R, Zander A, Dicke A, Alexanian R: High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 67:1298, 1986
10. Barlogie B, Alexanian R, Dicke KA, Zagars G, Spitzer G, Jagganath S, Horwitz L: High-dose chemotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 70:869, 1987
11. Jagganath S, Barlogie B, Dicke K, Alexanian R, Zagars G, Cheson B, Lemaistre FC, Smallwood L, Pruitt K, Dixon DO: Autologous bone marrow transplantation in multiple myeloma: Identification of prognostic factors. Blood 76:1860, 1990
12. Jagganath S, Vesole DH, Barlogie B, Tricot G: Peripheral blood stem cell transplantation in multiple myeloma. Ann Hematol/ Oncol 2:53, 1994
13. Comenzo RL, Berkman EM: Hematopoietic stem and progenitor cells from blood: Emerging uses for new components for transfusion. Transfusion 35:335, 1995
14. Skinner M, Anderson JJ, Simms R, Falk R, Wang M, Libbey CA, Jones LA, Cohen AS: Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 100:290, 1996
15. Cohen AS, Skinner M: The diagnosis of amyloidosis, in Cohen AS (ed): Laboratory Diagnostic Procedures in the Rheumatic Diseases (ed 3). Orlando, FL, Grune and Stratton, 1985, p 377
16. Comenzo RL, Vosburgh E, Weintraub LW, Tansan S, Arkin CF, Wright DG: Mobilized peripheral blood stem and progenitor cells for hematopoietic rescue collected by large-volume leukapheresis. Transfusion 35:493, 1995
17. Investigator's Handbook: A Manual for Participants in Clinical Trials of Investigational Agents Sponsored by the Division of Cancer Treatment, National Cancer Institute, Revised Edition. Washington, DC, Government Printing Office, 1993 (NIH publication no. 93-2770)
18. Mehta J, Nagler A, Slavin S: Marrow transplantation in multiple myeloma (letter). N Engl J Med 326:1087, 1992
19. Gharton G: Marrow transplantation in multiple myeloma (letter). N Engl J Med 326:1087, 1992
20. Barlogie B: Marrow transplantation in multiple myeloma (letter). N Engl J Med 326:1088, 1992
21. Kelly JJ, Kyle RA, O'Brien PC, Dyck PJ: The natural history of peripheral neuropathy in primary systemic amyloidosis. Ann Neurol 6:1, 1979
22. Dustin MA, Skinner M, Anderson J, Cohen AS: Peripheral neuropathy as an early marker of AL amyloidosis. Arch Intern Med 149:358, 1989
23. Gahrton G, Tura S, Ljungman P, Belanger C, Brandt L, Cavo M, Facon T, Granena A, Gore M, Gratwohl A, Lowenberg B, Nikoskelainen J, Reiffers JJ, Samson D, Verdonck L, Volin L: Allogeneic bone marrow transplantation in multiple myeloma. N Engl J Med 325:1267, 1991
24. van Buren M, Hene RJ, Verdonck LF, Verzijlbergen FJ, Lokhorst HM: Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis. Ann Intern Med 122:508, 1995
25. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsman R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994
26. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klump TR, Kahn DG, Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993
27. Moss TJ, Ross AA: The risk of tumor cell contamination in peripheral blood stem cell collections. J Hematotherapy 1:225, 1992
28. Gazitt Y, Reading CC, Hoffman R, Wickrema A, Vesole DH, Jagganath S, Condino J, Lee B, Barlogie B, Tricot G: Purified CD34+ Lin-Thy+ stem cells do not contain clonal myeloma cells. Blood 86:381, 1995
29. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
30. Negrin RS, Pesando J: Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. J Clin Oncol 12:1021, 1994
31. Schiller G, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M, Wu CH, Cao J, Lee JC, Hong CH, Lichtenstein A, Lill M, Hall J, Berenson R, Berenson J: Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995